These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38674157)

  • 1. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
    Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
    Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
    Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
    Busch M; Papior D; Stephan H; Dünker N
    Oncol Rep; 2018 Jan; 39(1):160-172. PubMed ID: 29192327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism.
    Song WP; Zheng S; Yao HJ; Zhou XF; Li R; Zhang CY; Zhao JY; Wang LW; Shao RG; Li L
    BMC Ophthalmol; 2020 Mar; 20(1):92. PubMed ID: 32143590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress.
    Kong M; Han Y; Zhao Y; Zhang H
    Med Sci Monit; 2020 Jul; 26():e923817. PubMed ID: 32641679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
    Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
    Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway.
    Wan W; Wan W; Long Y; Li Q; Jin X; Wan G; Zhang F; Lv Y; Zheng G; Li Z; Zhu Y
    Biomed Pharmacother; 2019 Oct; 118():109111. PubMed ID: 31336343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
    Reinhard J; Wagner N; Krämer MM; Jarocki M; Joachim SC; Dick HB; Faissner A; Kakkassery V
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression.
    Lu X; Tu H; Tang D; Huang X; Sun F
    Curr Eye Res; 2022 Mar; 47(3):418-425. PubMed ID: 34547965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
    Yang G; Fu Y; Lu X; Wang M; Dong H; Li Q
    Int J Oncol; 2019 Jan; 54(1):177-187. PubMed ID: 30387834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis.
    Zhong L; Meng X; Huang J; Hao W; Zuo Y
    Chin Clin Oncol; 2023 Oct; 12(5):52. PubMed ID: 37964544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
    Kandalam MM; Beta M; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2012; 18():2279-87. PubMed ID: 22969266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53, miR-34a and EMP1-Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells.
    Busch M; Klein S; Große-Kreul J; Scheiner O; Metz K; Stephan H; Dünker N
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.
    Guo L; Bai Y; Ni T; Li Y; Cao R; Ji S; Li S
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34036380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
    Sun QX; Wang RR; Liu N; Liu C
    Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.
    Mergler S; Cheng Y; Skosyrski S; Garreis F; Pietrzak P; Kociok N; Dwarakanath A; Reinach PS; Kakkassery V
    Exp Eye Res; 2012 Jan; 94(1):157-73. PubMed ID: 22182671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
    Fu K; Zhang K; Zhang X
    Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
    Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
    Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.